tradingkey.logo
tradingkey.logo
Search

Assertio Holdings rises after $166 million buyout by Zydus

ReutersMay 13, 2026 12:52 PM
facebooktwitterlinkedin
View all comments0

Shares of drugmaker Assertio Holdings ASRT.O rise 3.7% to $23.38 premarket

ASRT says Indian drugmaker Zydus Lifesciences ZYDU.NS will acquire the company for $23.50 per share or $166.4 million

The offer from Zydus Lifesciences' subsidiary Zydus Worldwide DMCC, tops Assertio's earlier merger agreement with Garda Therapeutics, ASRT says

Through the deal, Zydus will gain 8 FDA approved drugs for various conditions

Zydus' offer represents a 4% premium to ASRT's last close

The offer represents a 30.6% premium to Garda's original $18-per-share cash offer announced in April, and a 7.8% premium to Garda's revised $21.80-per-share offer announced on May 4, Assertio said

Assertio says the deal is expected to close in the second quarter of 2026

As of last close, ASRT was up 148% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI